Cancer Action Events

Share

FILTER BY:

August 6, 2021EST

Health inequities adversely affect groups of people who have systematically experienced greater social or economic obstacles to health based on their racial or ethnic group, socioeconomic status, gender, sexual orientation or gender identity; geographic location; or other characteristics historically linked to discrimination or exclusion. ACS CAN believes no matter your...

August 10, 2021EST

We are so excited to announce that Delaware's own, Chef Dana Herbert is hosting a fundraiser to benefit ACS CAN Delaware! Any donation to our Lights of Hope page made from now till EOD August 9th will get you access to a virtual baking class with the Chef. You will...

August 18, 2021PST

Register today for the virtual ACS CAN Nevada Policy Forum. This ACS CAN Nevada annual policy event explores the intersection of oncology and public policy. Join 100+ participants, including state policymakers, providers, health advocates, and industry partners as they delve into the critical role of cancer research in helping...

August 18, 2021

Join ACS CAN Minnesota and partners on Wednesday, August 18 for a discussion on access to cancer research and clinical trial across Minnesota, and what researchers need to ensure all patients can equitably access the latest innovations in cancer care and treatment. Every new breakthrough in freeing the world from...

September 8, 2021CST

ACS CAN is hosting virtual education events in selected states to educate policymakers, partners and volunteers about biomarker testing and current barriers and lay groundwork for future legislative campaigns to expand access to biomarker testing. Please join ACS CAN Texas for this special presentation on Wednesday, September 8th at 12...

September 9, 2021EST
FL

The American Cancer Society Cancer Action Network (ACS CAN) is hosting virtual education event on Thursday, September 9 th at 1PM on the rapidly advancing world of precision medicine in cancer care, as well as the importance of increasing patient access to biomarker testing and targeted cancer therapies. A panel...